Real-time enrollment status for this left-sided colorectal cancer clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 7:00 AM UTC
| NCT Number | NCT07702032 |
| Recruiting Status | Recruiting |
| Condition | Left-sided Colorectal Cancer |
| Phase | PHASE3 |
| Target Enrollment | 960 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Genmab |
| Last Updated on CT.gov | October 6, 2026 (1 week ago) |
As of October 19, 2026: Clinical trial NCT07702032 is currently recruiting participants. This phase3 study for left-sided colorectal cancer is actively seeking new participants at 7 locations across the United States. The study is sponsored by Genmab. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07702032 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07702032 was last updated 1 week ago (October 6, 2026). HelloStudys verifies this status automatically.